Synthesis and Encapsulation of a New Zinc Phthalocyanine Photosensitizer into Polymeric Nanoparticles to Enhance Cell Uptake and Phototoxicity
Source abstract
Abstract
Efforts to enhance the utility of photodynamic therapy as a non-invasive method for treating certain cancers have often involved the design of dye sensitizers with increased singlet oxygen efficiency. More recently, however, sensitizers with greater selectivity for tumor cells than surrounding tissue have been targeted. The present study provides an approach to the modification of the known photosensitizer zinc phthalocyanine (ZnPc), to enhance its solubility and delivery to cancer cells. Targeting a photosensitizer to the site of action improves the efficacy of the sensitizer in photodynamic therapy. In this work we used PLGA-b-PEG to encapsulate a new zinc phthalocyanine derivative, 2(3), 9(10), 16(17), 23(24)-tetrakis-(4’-methyl-benzyloxy) phthalocyanine zinc(II) (ZnPcBCH3), to enhance uptake into A549 cells, a human lung cancer cell line. ZnPcBCH3 exhibited the same photochemical properties as the parent compound ZnPc but gave increased solubility in organic solvents, which allowed for efficient encapsulation. In addition, the encapsulated dye showed a near 500-fold increase in phototoxicity for A549 cancer cells compared to free dye.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Porphyrin and Phthalocyanine Chemistry · Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Fiber and Polymer Science program, North Carolina State University, Raleigh, NC 27606, USA
James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37684, USA
References (30)
Show source-provided references
1. Photodynamic therapy: A new antimicrobial approach to infectious disease?10.1039/b311900a ↗
2. Photodynamic therapy in dentistry: A literature review10.1007/s00784-012-0845-7 ↗
3. Can BODIPY Dimers Act as, Photosensitizers in Photodynamic Therapy? A Theoretical Prediction10.3389/fphy.2018.00143 ↗
4. Investigating the excited state optical properties and origin of large stokes shift in Benz[c,d]indole N-Heteroarene BF2 dyes with ab initio tools10.1016/j.jphotobiol.2017.12.006 ↗
5. Klán, P., and Wirz, J. (2009). Photochemistry of Organic Compounds: From Concepts to Practice, Wiley.10.1002/9781444300017 ↗
6. Developments in PDT sensitizers for increased selectivity and singlet oxygen production10.3390/ma8074421 ↗
7. Spatial and temporal dynamics of in vitro photodynamic cell killing: Extracellular hydrogen peroxide mediates neighbouring cell death10.1039/b815343d ↗
8. In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles10.1039/c0cc01413c ↗
9. Monomeric pheophorbide (a)-containing poly (ethyleneglycol-b-ε-caprolactone) micelles for photodynamic therapy10.1039/b811248g ↗
10. A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy10.1016/j.jconrel.2011.06.034 ↗
11. Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice10.1007/s10103-009-0740-x ↗
12. Nanostructured delivery system for zinc phthalocyanine: Preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells
13. Amphiphilic zinc phthalocyanine photosensitizers: Synthesis, photophysicochemical properties and in vitro studies for photodynamic therapy10.1039/C5DT00747J ↗
14. Nanostructures of an amphiphilic zinc phthalocyanine polymer conjugate for photodynamic therapy of psoriasis10.1016/j.colsurfb.2015.02.038 ↗
15. Conducting polymer nanoparticles for targeted cancer therapy10.1039/C5RA05125H ↗
16. New amphiphilic silicon (IV) phthalocyanines as efficient photosensitizers for photodynamic therapy: Synthesis, photophysical properties, and in vitro photodynamic activities10.1002/chem.200400462 ↗
17. Photochemical internalization of tamoxifens transported by a “Trojan-Horse” nanoconjugate into Breast-Cancer cell lines10.1002/anie.201500183 ↗
18. Synthesis and characterization of novel soluble phthalocyanines with fused conjugated unsaturated groups10.1016/j.dyepig.2010.10.002 ↗
19. Excited state processes in ruthenium (II)/pyrenyl complexes displaying extended lifetimes10.1021/jp011770f ↗
20. Solvent effects on the photochemical and fluorescence properties of zinc phthalocyanine derivatives10.1016/S0022-2860(03)00155-8 ↗
21. Synthesis, properties, and photodynamic inactivation of escherichia coli using a cationic and a noncharged zn (II) pyridyloxyphthalocyanine derivatives10.1016/j.bmc.2005.01.063 ↗
22. Cancer nanotechnology: Opportunities and challenges10.1038/nrc1566 ↗
23. Novel self-assembled core–shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release10.1016/j.jconrel.2009.05.013 ↗
24. McNeil, S. (2011). Zeta potential measurement. Characterization of Nanoparticles Intended for Drug Delivery, Springer.10.1007/978-1-60327-198-1 ↗
25. Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin10.1073/pnas.88.6.2051 ↗
26. Structural and immunologic characterization of bovine, horse, and rabbit serum albumins10.1016/j.molimm.2012.05.011 ↗
27. Dörwald, F.Z. (2012). Lead Optimization for Medicinal Chemists: Pharmacokinetic Properties of Functional Groups and Organic Compounds, Wiley-VCH.
28. Effect of molecular characteristics on cellular uptake, subcellular localization, and phototoxicity of Zn(II) N-alkylpyridylporphyrins10.1074/jbc.M113.511642 ↗
29. Mitochondrially targeted antioxidants and thiol reagents10.1016/S0891-5849(00)00255-0 ↗
30. Selective targeting of a redox-active ubiquinone to mitochondria within cells: Antioxidant and antiapoptotic properties10.1074/jbc.M009093200 ↗